Skip to content
Richard Peek
Home
Contact Me
Publications
Richard Peek
←
Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
Tirzepatide: A new anti-obesity medication
→
Reply
Posted on
September 22, 2022
by
Gastroenterology Journal
This entry was posted in
News
. Bookmark the
permalink
.
←
Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
Tirzepatide: A new anti-obesity medication
→
Links
Gastroenterology
MyVUMC
September 2022
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Oct »
Other websites
Etiological Studies of Gastric Carcinoma
H. pylori and Gastric Cancer
